ADHERELY

T HE HI GH COS T S OF P H A R M AC E UTIC AL RE S EAR C H

L E T' S DO T HE M AT H

D EMYTH OLOG IZI N G

IN D US TRY C OS TS
$ $
$

$802 MILLION

$1.32 BILLION

2000

2006

T HE ARTIFIC IA L FAC T
TRY LEADERS S U ,E IND

WE NEED YOUR MONEY FOR R&D

T HE Y T E L L U S T HAT R & D R E Q UIR E S HIGH PRICES

C OMP A N I E S TIGHTLY C O NTR O L AC CES S T O VE RIF IA B L E FACT S A B OU T T HE I R R I S KS A N D C O S T S , A L LOW I N G AC C ESS O NLY TO SUP P ORT ED E CON OM IS T S AT CON S U LT IN G F I R M S A N D U N I V E R S IT IE S

2000 R&D COSTS STUDY : $802 MILLION

US C OMPANIES

THE

ISTS, BIG C M O N OM O C

POLITICIAN , C I L S PUB

DID NOT ACCOUNT FOR THERAPEUTIC CLASSES. NO ADJUST MENT FOR TAX-PAYER SUBSIDIES OR DEDUCTIO NS. ADDED COSTS OF RETURNS FROM FUNDS THAT WOULD HAVE BEEN INVESTED IN THE STOCK MARKET WERE THE R&D PROJECT NOT UNDERTAKEN. THE COSTS REPORTED WERE NOT VERIFIED.

WHAT COSTS ARE THEY REPORTING?

INIS

LA

ND BUI LD A IN ND

ION FEES & E T A Q TR

ADM

E DEV
EXPENSES FO R

LO P I N G P A TE

F E E S P AY E D T

CTORS FOR O D C O

N T IO

PRO

L GA

T FOR MEDI CA R L PO

NICAL UPG RA

COSTS OF DISCOVERY
F OR R E C E NT B R EAKT H RO U G H DR UG S , R ES EAR C H S HO WS THAT:

SP EN T $ 2 BILLION

K E Y C O M P A N IE S

H TEC

WAIT THERES MORE!

EV ID E NCE AL S O S UG G E S T S T H AT T H E ES T IM AT ED CO S T S P ER T R IAL A R E INF L ATE D

TIME FOR R&D ARE ALSO EXAGGERATED COMPANY FINANCIAL RISKS ARE ALSO MUCH LOWER THAN CLAIMED AS RISKS ARE SPREAD OVER MULTIPLE PROJECTS

WHY NOT OPEN SOURCE THE DATA?

OF R&D

COSTS

P R OM ISE S TO S A VE

M ILLIO NS

M O RE LIV E S

QU E S T ION A BL E

Q U E S T IO N A B L E

QUOTED R&D COSTS SHOULD BE SUBJECT TO ANALYSIS

SUPPORT THE OPEN SOURCING OF CLINICAL TRIALS AT ALLTRIALS.NET
WWW.ADHERELY.COM
DESIGN BY WWW.JESSICADRAWS.COM
DATA F ROM: HT T P:/ / WWW.P HA R M A M Y T H S . N ET / FILES / BIO S O CIET IES_20 11_MY TH S_OF _H IG H _D R U G _R E SE A R C H _C OSTS. P D F

RU

SUP

U JO

R N A L S T H AT S

L I K E S O F T WA , S R DE

MEDICAL JOURNAL

OPEN SO UR C E

W HY NOT

DATA?
ADHERELY

CL INICAL TRIALS

$
UIP
MEN
T

$
IES PAN
GS
LEGAL DEF EN S&
UP
POR
T THE NEW

CE

$2.16 BILLION

2012

FOR NEW

OURNALISTS DJ AN
INVIT ED

24

ACCEPT ED

US COMPANIE S

12 10
PROVI D ED
U S C O M P A N IES

DATA

D
RU

NT

LIN

GS

ICAL
TRIALS

EO

R COMPUTERS

S P E N T $ 10 B ILLION

US GOV E R NME NT